摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone | 1173910-03-6

中文名称
——
中文别名
——
英文名称
1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone
英文别名
2-(4-Hydroxyphenyl)-1-(2,3,4-trihydroxyphenyl)propan-1-one
1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone化学式
CAS
1173910-03-6
化学式
C15H14O5
mdl
——
分子量
274.273
InChiKey
XTSWJTBIEXVATN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    98
  • 氢给体数:
    4
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    2-(4-羟基苯)丙酸邻苯三酚三氟化硼乙醚 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.17h, 以72%的产率得到1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone
    参考文献:
    名称:
    Synthesis of Various Kinds of Isoflavones, Isoflavanes, and Biphenyl-Ketones and Their 1,1-Diphenyl-2-picrylhydrazyl Radical-Scavenging Activities
    摘要:
    合成了四十八种异黄酮(8)、三十一种异黄烷(9)以及四十七种联苯酮(10, 10′),这些化合物是由十一种取代酚(11)和六种苯乙酸(12)合成的。其中,有七十五种化合物是新发现的。这些化合物的自由基清除活性在pH 6.0下使用1,1-二苯基-2-吡唑啉酮(DPPH)进行了评估。我们发现,在四十三种含有儿茶酚基的化合物中,三十九种在A环或B环上表现出与儿茶素相似的高活性(ED50=12—54 μM)。在这些情况下,它们结构的其他部分似乎对活性影响不大。许多6-或8-羟基异黄烷(9E—I)及其联苯酮衍生物(10E—H)也显示出高活性(ED50=<50 μM),而它们对应的异黄酮(8E—I)则完全没有活性。具有在C5位增加羟基(9D)或在C6位增加甲氧基(9J)的7-羟基异黄烷则展现出高活性(ED50=26—32 μM)。本研究表明,天然异黄酮通过在C6、C8或C3′位置的羟基化,或通过代谢或生物转化形成异黄烷(9)和/或联苯酮衍生物(10′),具有表现抗氧化活性的可能性。
    DOI:
    10.1248/cpb.57.346
点击查看最新优质反应信息

文献信息

  • Phenyl-benzyl-ketones
    申请人:G.J. Consultants Pty Ltd
    公开号:EP1743881A1
    公开(公告)日:2007-01-17
    There are disclosed compounds of formulae (I) or (II) in which A is selected from the group consisting of (1), (2), (3) and (4);OH, and one of R1 and R2 is selected from H, OH and OCH3, and the other of R1 and R2 is selected from OH and OCH3; one of R3 and R4 is selected from H, OH and OCH3, and the other of R3 and R4 is selected from OH and OCH3; provided that at least one of the pairs R1, R2 and R3, R4 are both OH; R5 is selected from OH and OCH3; and ----- denotes a single or double bond; and pharmaceutically acceptable salts and prodrugs thereof. The compounds of the invention are useful for the treatment of hormone-dependent conditions and cancers.
    公开了式(I)或(II)化合物,其中 A 选自(1)、(2)、(3)和(4)组成的组;OH,R1 和 R2 中的一个选自 H、OH 和 OCH3,R1 和 R2 中的另一个选自 OH 和 OCH3;R3和R4中的一个选自H、OH和OCH3,R3和R4中的另一个选自OH和OCH3;条件是R1、R2和R3、R4中至少有一对都是OH;R5选自OH和OCH3;----- 表示单键或双键;及其药学上可接受的盐和原药。本发明的化合物可用于治疗激素依赖性疾病和癌症。
  • POLYPHENYLENE ETHER OLIGOMER AND ARTICLE EMPLOYING THE SAME
    申请人:INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    公开号:US20140323666A1
    公开(公告)日:2014-10-30
    A polyphenylene ether oligomer is provided. The polyphenylene ether oligomer has the following formula (I): X is R is H or C 1-6 alkyl group; Y independently is a moiety polymerized by at least two different phenol-based compounds; and Z independently is H, acryloyl group, allyl group, vinylbenzyl group, epoxypropyl group, methylacryloyl group, propargyl group, or cyanoallyl group.
  • US9012572B2
    申请人:——
    公开号:US9012572B2
    公开(公告)日:2015-04-21
  • Synthesis of Various Kinds of Isoflavones, Isoflavanes, and Biphenyl-Ketones and Their 1,1-Diphenyl-2-picrylhydrazyl Radical-Scavenging Activities
    作者:Hideyuki Goto、Yoshiyasu Terao、Shuji Akai
    DOI:10.1248/cpb.57.346
    日期:——
    Forty-eight kinds of isoflavones (8), thirty-one isoflavanes (9), and forty-seven biphenyl-ketones (10, 10′) were synthesized from eleven kinds of substituted phenols (11) and six phenylacetic acids (12). Among them, seventy-five compounds are new. The radical scavenging activities of these compounds were evaluated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) at pH 6.0. We found that thirty-nine out of forty-three compounds having a catechol moiety on either the A- or the B-ring exhibited a high activity (ED50=12—54 μM) similar to that of catechin. In these cases, the remaining part of their structure seemed to have little effect on their activity. Many 6- or 8-hydroxyisoflavanes (9E—I) and their biphenyl-ketone derivatives (10E—H) also showed a high activity (ED50=<50 μM), while all of their corresponding isoflavones (8E—I) were not active at all. The 7-hydroxyisoflavanes having either an additional hydroxyl group at the C5-position (9D) or a methoxy group at the C6-position (9J) presented a high activity (ED50=26—32 μM). This study suggests that natural isoflavones have the possibilities of exhibiting antioxidant activities through the hydroxylation at the C6-, C8-, or C3′-position or the formation of the isoflavanes (9) and/or the biphenyl-ketone derivatives (10′) by metabolism or biotransformation.
    合成了四十八种异黄酮(8)、三十一种异黄烷(9)以及四十七种联苯酮(10, 10′),这些化合物是由十一种取代酚(11)和六种苯乙酸(12)合成的。其中,有七十五种化合物是新发现的。这些化合物的自由基清除活性在pH 6.0下使用1,1-二苯基-2-吡唑啉酮(DPPH)进行了评估。我们发现,在四十三种含有儿茶酚基的化合物中,三十九种在A环或B环上表现出与儿茶素相似的高活性(ED50=12—54 μM)。在这些情况下,它们结构的其他部分似乎对活性影响不大。许多6-或8-羟基异黄烷(9E—I)及其联苯酮衍生物(10E—H)也显示出高活性(ED50=<50 μM),而它们对应的异黄酮(8E—I)则完全没有活性。具有在C5位增加羟基(9D)或在C6位增加甲氧基(9J)的7-羟基异黄烷则展现出高活性(ED50=26—32 μM)。本研究表明,天然异黄酮通过在C6、C8或C3′位置的羟基化,或通过代谢或生物转化形成异黄烷(9)和/或联苯酮衍生物(10′),具有表现抗氧化活性的可能性。
查看更多

同类化合物

安哥拉紫檀素 2-羟基-3-苯基苯丙酮 1-(2,4-二羟基苯基-3,5-d2)-2-(4-羟基苯基-3,5-d2)丙烷-1-酮-2-d1 1-(2,4-二羟基苯基)-2-(4-羟基苯基)丙-1-酮 1-(1-羟基萘-2-基)-2-甲基-2-苯基丙烷-1-酮 1-(2-hydroxy-5-methylphenyl)-3-(naphthalen-1-yl)-2-phenylpropan-1-one 2,4,5,4'-tetramethoxy-α-methyldesoxybenzoin 1-[2-(1-hydroxynaphthyl)]-2-phenyl-1-propanone 1-(4-(cyc lohexyloxy)-2-methoxyphenyl)-2-(3,4-dimethoxyphenyl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(4-hydroxy-2-methoxyphenyl)propan-1-one 1-(2-Hydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one 1-(2-methoxyphenyl)-2-phenylpropan-1-one 2-(2-fluorophenyl)-1-(2-methoxy-4-(piperidin-1-yl)phenyl)propan-1-one (-)-angolensin (-)-angolensin-4-methyl ether 1-(2-methoxyphenyl)-2-phenyl-2-(trimethylsilyloxy)propan-1-one 1-(2,5-dimethoxy-4-methylphenyl)-2-phenylpropan-1-one (+/-)-1-<2,5-Dimethyl-phenyl>-2-phenyl-propan-1-on 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-[1,2,3-(13)C3]propan-1-one 1,2-bis(2-hydroxybenzoyl)-1-propanone 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)-2-methylpropan-1-one (+/-)-2-<2,4-Bis(methoxymethoxy)phenyl>-1-<2-hydroxy-4-(methoxymethoxy)phenyl>propan-1-on 1-(2-hydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-phenylpropan-1-one 1-(2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1-propanone 2-hydroxy-3,4-dimethoxy-α-C-methoxydesoxybenzoin (R)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(5-Bromo-2-hydroxyphenyl)-2-(2-nitrophenyl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-phenyl-1-propanone 1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one 1-(2,3,4-trihydroxyphenyl)-2-phenyl-1-propanone (S)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one Ethyl 4-[1-[4-(dimethylamino)-2-hydroxyphenyl]-1-oxopropan-2-yl]benzoate 2-[[2-(2-Methyl-2-phenylpropanoyl)phenoxy]methoxy]propyl benzoate (2S)-1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-[2,4-Bis(trimethylsiloxy)phenyl]-2-[(4-trimethylsiloxy)phenyl]propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)propan-1-one (+/-)-Di-O-acetyl-angolensin 4'-hydroxy-2,4-dimethoxy-α-methyldeoxybenzoin 1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(2,4-Dihydroxyphenyl)-2-(3-hydroxy-4-methoxyphenyl)propan-1-one 2-(4-Methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one 1-(2,4-Dihydroxyphenyl)-2-(3,5-dimethoxyphenyl)propan-1-one 1-[4-[(1,6-dimethyl-4-propan-2-yl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-yl)oxy]-2-hydroxyphenyl]-2-(4-methoxyphenyl)propan-1-one 1-(2,4-Dihydroxy-5-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one (+/-)-4-O-methylangolensin